Literature DB >> 16675652

Effect of internal reporting criteria on suspected adverse drug reactions submitted to MedWatch.

Kelly M Smith1, Amber P Lawson, Sony Tuteja.   

Abstract

Mesh:

Year:  2006        PMID: 16675652     DOI: 10.2146/ajhp050381

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  1 in total

1.  Registries, research, and regrets: is the FDA's post-marketing REMS process not adequately protecting patients?

Authors:  Norman J Kachuck
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.